Search

everythinglearnresearchcommunity

for

Search:↓

The immune processes causing VKH and vitiligo are similar in dogs and humans.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

Testosterone, progesterone, and levonorgestrel change enzyme levels related to fat production in hamster skin, which could affect skin oil and acne.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

A drug improved schizophrenia-like symptoms in stressed rats by changing brain steroid levels.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Human skin acts like a hormone-producing organ, making and managing various hormones important for skin and hair health.

Some lesser-known causes of PCOS include autoimmune issues, genetic mutations, and changes in the body's microbiome.

Rosa rugosa extract promotes hair growth and could be a natural treatment for hair loss.

miR-199a-3p controls hair growth and is linked to alopecia areata.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

Finasteride affects brain processes related to neurotransmission and metabolism, potentially helping with neuropsychiatric conditions.

Exosomes from fat-derived stem cells can potentially improve hair growth and could be a new treatment for immune-related hair loss.

No link found between specific genes and female pattern hair loss.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

CO2 laser treatment for aging skin significantly changes immune system-related genes.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Substances from fat-derived stem cells can promote hair growth and counteract hormone-related hair loss by activating a key hair growth pathway.

Mothers have more hair proteins than their children, with age-related differences in protein patterns, and some proteins in hair could indicate early childhood development.

The vitamin D receptor is involved in multiple body functions beyond calcium regulation, including immune response and rapid reactions not related to gene activity.

The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.

The document concludes that understanding the sebaceous gland's development and function is key to addressing related skin diseases and aging effects.

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.

Finasteride treatment changes urine metabolomics and steroid signatures, potentially monitoring effectiveness but may cause sexual side effects.

The enzyme 5α-reductase type 1 is important for blood vessel development and fertility in the uterus.

Germacrene analogs, especially 8-Hydroxy germacrene B, are more effective than germacrone at blocking a hormone-related enzyme and could help treat hair loss.